All Type of News
Febuxostat, effectve treatment for chronic gout and hyperuricemia
SK Chemicals and SK Pharm said that TAP Pharmaceutical Products Inc., a joint venture between Abbott and Takeda Pharm, announced its October 19 data showing its investigational medication, febuxostat (codename: TMX-67...
Only interview without seniority for high official promotion.
The MOHW plans to adopt an interview promotion system without prior personnel records for the assessment of the 5th grade administration official's promotion instead of the conventional seniority system in order to ke...
Smaller package of drug gaining popularity in pharmacy
Pharmaceutical business sources said the supply of drugs in smaller package would be further expanded as part of enhancing the brand image amid growing demand from pharmacies and customers since the implementation of ...
62% households in Seoul still possess drugs after use
62% households in Seoul are still reluctant to destroy cold remedies, digestives and ointments after use, according to a local survey.
The survey of 192 citizens residing in Seoul conducted by the Korea Pharmaceuti...
Pharmacy recession to shake other related business
A chronic business recession in the pharmacy market has substantially battered the related business such as the pharmacy franchise companies, facing with financial difficulties and management confusions as much seriou...
Pharmacy College Faculty group to support 6 year school system.The Korea Pharmacy College Faculty Council (chief: Sohn Young-taek) met together under the Regular Fall Conference at Kyunghee Univ. Main hall conference room on Oct. 29 and for...
|
KFDA launches site of Scientific Information on Drug Abuse
The Korea Food and Drug Administration said it has launched its website of Scientific Information on Drug Abuse (SIDA; sida.kfda.go.kr) on internet as part of providing up-to-date scientific data on 279 narcotics, inc...
Korean competitors challenge Pfizer's leadership in amlodipine
Korea's major pharmaceutical firms are racing to increase their market share in the domestic amlodipine market, prompting speculation that Pfizer Korea, a Korean unit of a multinational pharmaceutical firm, may face a...
Drug makers unlikely dealing directly with hospitals.
In replying to the question raised by President Eric Ruts of Novo Nordisk Co. during the luncheon meeting invited by EU chamber of commerce on Oct. 28, Minister Kim Keun-tae of MOHW said that the pharmaceutical indust...
Government funding may encourage local R&D projects, KPMA says
The Korean government's substantial R&D investment will enable local pharmaceutical firms to spur their R&D new drug projects in the years ahead, said an official from the Korea Pharmaceutical Manufacturers Associatio...
